Mylan NV (MYL)

MYL (NASDAQ:Drugs) EQUITY
$59.35
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | MYL Avg Daily Volume: 4,078,200
Last Update: 03/31/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 5.29%
Open: $0.00
Previous Close: $59.35
52 Week Range: $44.74 - $65.63
Oustanding Shares: 378,373,668
Market Cap: 22,702,420,080
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 9
Moderate Buy 1 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.21 1.33 1.36 1.36
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 25.64
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
25.64 25.70 27.63
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.29% 21.54% 153.09%
GROWTH 12 Mo 3 Yr CAGR
Revenue 11.70 0.26 0.08
Net Income 48.90 0.73 0.20
EPS 47.70 0.99 0.26
Earnings for MYL:
EBITDA 1.89B
Revenue 7.72B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.78 $1.01 $4.15 $4.64
Number of Analysts 5 4 10 9
High Estimate $0.95 $1.12 $4.23 $4.83
Low Estimate $0.69 $0.92 $4.00 $4.37
Prior Year $0.66 $0.69 $3.56 $4.15
Growth Rate (Year over Year) 18.48% 47.10% 16.69% 11.65%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Mar 23, 2015 | 6:00 AM EDT

Here are healthcare stocks of all shares and sizes with strong charts.

By

Bret Jensen

 | Feb 6, 2015 | 9:00 AM EST

A huge political headwind has been removed for this pharma.

By

Jim Cramer

 | Dec 22, 2014 | 1:12 PM EST

It might be good for consumers, but not for the stock.

By

David Katz

 | Nov 25, 2014 | 2:30 PM EST

Whether it's acquiring or the acquired, Mylan is building shareholder value.

By

Robert Moreno

 | Oct 23, 2014 | 1:57 PM EDT

And two reporting next week that look set to make a move. 

bullishMylan estimates, target boosted at BMO

Oct 6, 2014 | 8:10 AM EDT

Shares of MYL now seen reaching $42, according to BMO Capital. Estimates also upped, given the company's new guidance. Underperform rating. 

By

Robert Moreno

 | Sep 29, 2014 | 2:40 PM EDT

Four stocks that have been trading in triangle or wedge patterns.

By

Doug Kass

 | Sep 23, 2014 | 8:04 AM EDT
Where it began.

updateMYL Investor Mtg.

Sep 18, 2014 | 7:01 AM EDT

MYL - Mylan Inc Investor Day - NY

By

James "Rev Shark" DePorre

 | Jul 16, 2014 | 4:20 PM EDT

And a paucity of perky charts.

The risk of a 'Grexit' – Greece leaving the eurozone, possibly the European Union too...
The cluster of high wick candles that formed in February and early this month may have bee...
When the tide goes out is when we will find out how ugly things really are. The waters are...
Market ends the month and the quarter on a down note. Indices are largely flat for 2015, ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.